Clinical Trials Logo

Deep Learning clinical trials

View clinical trials related to Deep Learning.

Filter by:

NCT ID: NCT05058599 Recruiting - Deep Learning Clinical Trials

Reconstruction Technology to Auxiliary Diagnosis and Guarantee Patient Privacy

Start date: May 10, 2020
Phase:
Study type: Observational

Medical data that contain facial images are particularly sensitive as they retain important personal biometric identity, privacy protection. We developed a novel technology called "Digital Mask" (DM), based on real-time three-dimensional (3D) reconstruction and deep learning algorithm, to extract disease-relevant features but remove patient identifiable features from facial images of patients.

NCT ID: NCT05046366 Recruiting - Lung Cancer Clinical Trials

Development of an Artificial Intelligence System for Intelligent Pathological Diagnosis and Therapeutic Effect Prediction Based on Multimodal Data Fusion of Common Tumors and Major Infectious Diseases in the Respiratory System Using Deep Learning Technology.

Start date: October 1, 2021
Phase:
Study type: Observational

To improve accurate diagnosis and treatment of common malignant tumors and major infectious diseases in the respiratory system, we aim to establish a large medical database that includes standardized and structured clinical diagnosis and treatment information such as electronic medical records, image features, pathological features, and multi-omics information, and to develop a multi-modal data fusion-based technology system for individualized intelligent pathological diagnosis and therapeutic effect prediction using artificial intelligence technology.

NCT ID: NCT05041777 Active, not recruiting - Clinical trials for Basal Cell Carcinoma

Optical-Coherence Tomography for the Non-invasive Diagnosis and Subtyping of Basal Cell Carcinoma

OCT-BCC
Start date: February 15, 2017
Phase:
Study type: Observational

Rationale: To date, the diagnosis and subtyping of basal cell carcinoma (BCC) is verified with histopathology which requires a biopsy. Because this technique is invasive, new non-invasive strategies have been developed, including Optical Coherence Tomography (OCT). This innovative technique enables microscopically detailed examination of lesions, which is useful for diagnosing and identification of various subtypes of BCC. The diagnostic value of the VIVOSIGHT OCT in daily clinical practice, has not been established to date.

NCT ID: NCT04921488 Completed - Clinical trials for Colorectal Neoplasms

Interest of Artificial Intelligence in Cancer Screening Colonoscopy

IA COLO
Start date: October 21, 2021
Phase: N/A
Study type: Interventional

Artificial Intelligence (AI) to predict the histology of polyps per colonoscopy, offers a promising solution to reduce variation in colonoscopy performance. This new and innovative non-invasive technology will improve the quality of screening colonoscopies, and reduce the costs of colorectal cancer screening. The aim of the study is to performed a cross-sectional, multi-center study evaluating the diagnostic performance of the CAD EYE automatic characterization system for the histology of colonic polyps in colorectal cancer screening colonoscopy.

NCT ID: NCT04828187 Completed - Deep Learning Clinical Trials

Development and Validation of Deep Neural Networks for Blinking Identification and Classification

Start date: October 1, 2020
Phase:
Study type: Observational [Patient Registry]

Primary objective of this study is the development and validation of a system of deep neural networks which automatically detects and classifies blinks as "complete" or "incomplete" in image sequences.

NCT ID: NCT04824378 Recruiting - Deep Learning Clinical Trials

Study on Classification Method of Indocyanine Green Lymphography Based on Deep Learning

BCRL;ICG
Start date: October 1, 2016
Phase:
Study type: Observational

Breast cancer related lymphedema (BCRL) is the most common complication after breast cancer surgery, which brings a heavy psychological and spiritual burden to patients. For a long time, the diagnosis and treatment of lymphedema has been a difficult point in domestic and foreign research. To a large extent, it is because most of the patients who come to see a doctor have already developed obvious lymphedema, and the internal lymphatic vessels have undergone pathological remodeling[1] Therefore, it is particularly important to detect early lymphedema and intervene in time through the use of sensitive screening tools. Indocyanine green (ICG) lymphangiography is a relatively new method, which can display superficial lymph flow in real time and quickly, and will not be affected by radioactivity [7]. In 2007, indocyanine green lymphography was used for the first time to evaluate the function of superficial lymphatic vessels. In 2011, Japanese scholars found skin reflux signs based on ICG lymphography data of 20 patients with lymphedema after breast cancer surgery, and they were roughly divided into three types according to their severity: splash, star cluster, and diffuse (Figure 1) [8]. Later, in 2016, a prospective study involving 196 people affirmed the value of ICG lymphography in the early diagnosis of lymphedema, and made the images of ICG lymphography more specific stages 0-5 [9], but The staging is still based on the three types of skin reflux symptoms found in a small sample clinical study in 2011, which is not completely applicable in actual clinical applications. In addition, when abnormal skin reflux symptoms appear on ICG lymphangiography, the pathophysiological changes that occur in the body lack research and exploration. Therefore, this research hopes to refine the image features of ICG lymphography through machine learning (deep learning), and establish a PKUPH model for diagnosing early lymphedema by staging the image features.

NCT ID: NCT04592068 Recruiting - Retinal Diseases Clinical Trials

AI Classifies Multi-Retinal Diseases

Start date: November 1, 2020
Phase:
Study type: Observational

The objective of this study is to establish deep learning (DL) algorithm to automatically classify multi-diseases from fundus photography and differentiate major vision-threatening conditions and other retinal abnormalities. The effectiveness and accuracy of the established algorithm will be evaluated in community derived dataset.